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Background: Benzoic acid (BA) and salicylic acid (SA) combined are used as choice topical treatment for 
fungal and bacterial infections but their delivery is affected by ointment vehicle, among other factors. With aim 
to achieve improved release and antimicrobial activity in ointment formulation of these medicaments through 
selection of more efficient vehicle(s), this study comparatively evaluated prospective alternatives to the 
compendium-specified base for delivery potential and relevant physical properties. 
Methodology: Water-sorption capacity, rheological characteristics and heat-tolerance limits of six hydrophilic 
bases [hydrous ointment (HO), hydrous sheabutter (HS), neat sheabutter (NS), lanolin anhydrous (LA), lanolin 
hydrous (LH), and emulsifying ointment (EO)] and their ointment products containing 1, 2, 3, or 6% w/w of BA 
or SA were determined. Drug delivery propensity of the products was evaluated by agar diffusion colorimetric 
assay, while their antimicrobial activities were determined by hole-in-plate agar diffusion assay against selected 
type organisms (Bacillus subtilis, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Candida 
albicans and Candida pseudotropicalis). 
Results: BA was released in relatively larger quantity and demonstrated greater antimicrobial activity than SA 
in most bases. The released quantities of each medicament correlated directly with concentration and 
antimicrobial activities. The rates and extents of drug release followed a similar trend in different vehicles 
namely, HO > HS > NS ≥ EO > LA ≈ LH. Water number of base, ointment preparation method, viscosity, or 
heat-tolerance showed no influence on drug release or antimicrobial activity. 
Conclusion: HO and HS are better vehicles for delivery of BA and SA in ointment than EO which is the 
prototypical base. 
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Évaluation comparative des bases hydrophiles pour une 
meilleure administration d'acide benzoïque et d'acide 
salicylique dans une pommade antimicrobienne 
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Abstrait: 
 
Contexte: L'acide benzoïque (BA) et l'acide salicylique (SA) combinés sont utilisés comme traitement topique 
de choix pour les infections fongiques et bactériennes, mais leur administration est affectée par le véhicule de 
la pommade, entre autres facteurs. Dans le but d'améliorer la libération et l'activité antimicrobienne dans la 
formulation de pommade de ces médicaments grâce à la sélection de véhicules plus efficaces, cette étude a 
évalué comparativement des alternatives potentielles à la base spécifiée dans le compendium pour le potentiel 
d'administration et les propriétés physiques pertinentes.                            
Méthodologie: Capacité de sorption de l'eau, caractéristiques rhéologiques et limites de tolérance à la chaleur 
de six bases hydrophiles [pommade hydratée (HO), beurre de karité hydraté (HS), beurre de karité pur (NS), 
lanoline anhydre (LA), lanoline hydratée (LH), et onguent émulsifiant (EO)] et leurs produits de pommade 
contenant 1, 2, 3 ou 6% p/p de BA ou SA ont été déterminés. La propension à l'administration de médicaments 
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des produits a été évaluée par un essai colorimétrique de diffusion sur gélose, tandis que leurs activités 
antimicrobiennes ont été déterminées par un essai de diffusion sur gélose en plaque contre des organismes de 
type sélectionné (Bacillus subtilis, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Candida 
albicans et Candida pseudotropicalis).                                          
Résultats: BA a été libéré en quantité relativement plus grande et a démontré une plus grande activité 
antimicrobienne que SA dans la plupart des bases. Les quantités libérées de chaque médicament étaient 
directement liées à la concentration et aux activités antimicrobiennes. Les taux et l'étendue de la libération de 
médicaments ont suivi une tendance similaire dans différents véhicules, à savoir HO> HS> NS ≥ EO> LA ≈ LH. 
Le nombre d'eau de base, la méthode de préparation de la pommade, la viscosité ou la tolérance à la chaleur 
n'ont montré aucune influence sur la libération du médicament ou l'activité antimicrobienne.                 
Conclusion: HO et HS sont de meilleurs véhicules pour la livraison de BA et SA en onguent que EO qui est la 
base prototypique. 
 





 Ointments are semisolid pharma- 
ceutical dosage forms designed for appli- 
cation to human skin or to the surface of the 
eye or used nasally, vaginally or rectally for 
topical effect. Most ointments are used for the 
effects of the therapeutic agents they contain. 
Non-medicated ointments, on the other hand, 
are used for physical effects they provide on 
skin as protectants, emollients or lubricants. 
They are known as ointment bases and serve 
in medicated ointments as vehicles (carriers) 
for the therapeutic agents (1).   
 Benzoic acid is a crystalline, white or 
colourless solid organic compound (empirical 
formula: C6H5CO2H), slightly soluble in water 
(3.44g/L at 25°C). It is the simplest aromatic 
carboxylic acid also known as phenylcarbo 
xylic acid, phenylmethanoic acid, benzene ca- 
boxylic acid, or carboxybenzene (2). Benzoic 
acid as well as its salts and esters called 
benzoates possess antibacterial and anti- 
fungal properties and are included as ingre- 
dients of cosmetic products, used as pre- 
servative in foods and pharmaceutical pre- 
parations as preservative or as antiseptic 
agents. Salicylic acid, on the other hand, is a 
colourless or white crystalline, aromatic orga- 
nic solid compound with empirical formula, 
C6H4(OH)COOH, where the hydroxyl group is 
ortho to the carboxyl group. Salicylic acid is a 
lipophilic monohydroxybenzoic acid, that is 
also known as 2-hydroxybenzoic acid. It is a 
poorly water-soluble phenolic acid (solubility: 
2g/L at 20oC) (3). Salts and esters of salicylic 
acid are called salicylates and have medicinal 
(analgesic, anti-inflammatory) value. Salicylic 
acid, as a medication, is commonly used topi- 
cally (in ointment or cream) for its kerato- 
lytic, bacteriostatic and fungicidal properties, 
to treat warts, psoriasis, acne, ringworm, 
dandruff, and ichthyosis in pharmaceutical or 
skincare products (4).    
 The combined use of benzoic acid and 
salicylic acid in ointment preparation at 6 and 
3% concentrations respectively, known as 
Whitfield or compound benzoic acid ointment, 
was on the World Health Organization (WHO)  
 
list of essential medicines until the 16th 
update of 2009 (5,6). Its removal from the 
2011 list onward was not attributed to any 
safety reason or untoward effect but to avail-
ability of competitive alternative (7). Earlier, 
there had been a suggestion to enhance the 
release of Whitfield ointment’s medicaments 
by the use of a natural base plus surfactants 
as an alternative to emulsifying ointment, the 
vehicle recommended by official compendium 
(8).      
 The base used to prepare a semisolid 
medication exerts considerable control over 
the release and hence the therapeutic action 
of the medicament it carries. Two general 
approaches are used for topical preparations 
to maximize absorption of the active ingre- 
dient from the vehicle; inclusion of an agent 
that affects the barrier function of the epider- 
mis (9), or employment and development of 
a vehicle with physical characteristics that 
favour diffusion of the drug from the vehicle 
to the skin using an experimental procedure 
that measures drug release from the vehicle, 
from which the most suitable base is 
selected. In the latter approach however, 
inclusion of surfactant into semisolid base 
could contribute multifarious effects; some- 
times improving drug release (10,11), redu- 
cing release (12,13), or not affecting drug 
release at all (14).   
 Hydrophilic ointment bases are those 
permitting addition of water (or aqueous 
solutions) due to their water-miscibility or 
water absorption capacity. Their advantages 
over hydrophobic bases include being water-
washable (water-removable), compatible with 
normal skin functions and exhibiting more 
efficient or rapid drug delivery properties 
even with exclusion of surfactant (1,15). The 
aim of this study, therefore, was to compara- 
tively evaluate five hydrophilic ointment 
bases as prospective alternatives for imp- 
roved delivery of benzoic acid and salicylic 
acid from dispersion ointment formulation, 
and correlate the findings with concurrently 
determined antimicrobial activities of the 
medicaments in order to elucidate the factors 
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that may contribute to enhanced drug deli- 
very function.  
 
Materials and method:  
 
Study setting    
 The study was carried out at the 
postgraduate pharmaceutical technology and 
pharmaceutical microbiology laboratories of 
the Department of Pharmaceutics, Faculty of 
Pharmacy, Obafemi Awolowo University, Ile-
Ife, Nigeria.  
 
Materials    
 Materials used in the study were 
Benzoic acid (Fig 1A) and salicylic acid (Fig 
1B) (May and Baker, Dagenham, England) 
each screened through 180 μm-aperture 
(mesh no. 85) standard sieve (Okhard 
Machine Tools Co. Ltd, Lagos Nigeria); emul-
sifying wax (Evans Medical Ltd. Liverpool); 
liquid, white soft, and hard paraffin (William 
Ransom and Sons Plc. England); lanolin 
anhydrous, and wool alcohols (BDH, Poole, 
England).    
 Hydrophilic ointment bases studied 
were hydrous ointment (HO), hydrous shea- 
butter (HS), neat sheabutter (NS), lanolin 
anhydrous (LA), lanolin hydrous (LH), and 
emulsifying ointment (EO), having compo- 
sition as given in Table 1. Neat sheabutter 
was obtained by hot (60°C) filtration pro- 
cessing of natural sheabutter (16) procured 
at Shaki market, Oyo State, Nigeria, while 
lanolin anhydrous was as obtained from its 
manufacturer. Emulsifying ointment BP and 
hydrous ointment BP were prepared accor- 
ding to the compendium guidelines (17). 
Microbiological culture media used were 
Mueller-Hinton (MH), Nutrient agar (NA), and 
Sabouraud’s Dextrose agar (Rapid Labs Ltd, 
Colchester Essex, UK) which were prepared 














Determination of water number of ointment 
bases     
 The water number (water-sorption 
capacity) of the six ointment bases (10g 
samples) was determined at the ambient 
temperature (30±2°C) using the pharma- 
copeial method described for hydrous wool 
fat (17) and expressed conventionally as the 
volume of water (mL) absorbed per 100g of 
base.  
 
Preparation of medicated ointments  
 Two batches (100g each) of medi- 
cated ointment preparations were made with 
each ointment base using two different 
methods; levigation and fusion. In the levi- 
gation method, the medicament [benzoic acid 
at 1, 2, 3, or 6%; and salicylic acid at 1, 2, or 
3% (w/w) concentrations] was incorporated 
by mixing into the ointment base with spatula 
on glazed porcelain tile at the ambient tem-
perature (30±2ºC) until a uniform prepa- 
ration was attained. In the fusion method, 
however, mild heat (≤50°C) was applied to 
soften or melt the base, which facilitated 
subsequent incorporation of the medicament, 
followed by constant stirring of the prepa- 
ration while allowing it to cool until congealed 
(18). The medicated ointment samples, pack- 
aged (20g aliquots) in screw-cap (airtight) 
ointment jars were subsequently assessed for 
their physical stability and release properties 
as follows;  
 
Viscometric testing of ointments 
 Viscosity measurements were carried 
out on the bland and medicated ointment 
samples (20g each) at the ambient tempe- 
rature (30±2ºC) using a Rion VT-04F visco- 
tester, spindle no. 2 (Rion Co. Ltd, Tokyo 
Japan). The yield point value (initial peak) 
and viscosity of each sample were deter- 
mined for 30s. Any physical consistency 
changes in the sample under test were noted.  
 
Heat-tolerance limit testing of ointments
 Softening and melting temperatures 
of bland bases and of completed medicated 
ointments, and the congealing temperature 
values on cooling to ambient temperatures 
after melting, were determined using the 
method for suppository bases described by 
Adegboye and Itiola (19). Softening point 
was the temperature at which the sample 
began to liquefy, while melting point was the 
temperature of complete liquefaction. The 
mean and standard deviation (SD) of four 
determinations were recorded.  
 
Determination of in vitro drug-release from 
ointments    
 The drug release propensity of medi- 
cated ointments was determined by the agar 
diffusion colorimetric assay earlier described 
(20,21) and modified as follows; To 20mL of 
1% (w/v) bacteriological agar gel previously 
melted and cooled to 45°C was added and 
mixed gently 0.5mL of appropriate colour-
indicator solution, and poured into clean 90-
mm diameter Petri dishes and allowed to set. 
Five percent (w/v) aqueous solution of bromo- 
cresol green and ferric chloride served as the 
appropriate indicators for testing ointments 
containing benzoic acid and salicylic acid 
respectively. After 30 min, three equidistant 
cups (8.0 mm in diameter) were made into 
the agar plate using a sterile cork-borer and 
0.2mL (approximately 170mg) of medicated 
ointment sample was extruded from a 5mL 
glass syringe into each agar cup (triplicate 
experiments), placed such that it made uni- 
form contact with the agar gel.  
 The plates were incubated at 37°C in 
aerobic incubator. The diameters of colour-
zone changes produced around each cup as 
the medicament was released and diffused 
through agar from the ointment sample were 
measured at predetermined time intervals; 
10, 20, and 30 min intervals during the 1st, 
2nd, and until the 6th hours respectively, and 
then hourly, 2-hourly, and 4-hourly intervals 
until the 10th, 16th, and 24th hours respect- 
tively. The area of coloured zones was cal- 
culated from the mean diameter of each zone 
to indicate extent of the medicament rel- 
eased from ointment at the various data-
sampling times from which the rate of release 
was calculated. The release rate of benzoic 
acid or salicylic acid from each medicated 
ointment preparation in each base was deter- 
mined as the slope value in the regression 
line equation of the plot of diffusion-zone size 
of the medicament versus the square-root of 
time (22).  
 
Determination of antimicrobial activity of the 
ointment products  
 
Test microorganisms and culture conditions
 The test organisms used were 
Bacillus subtilis (NCTC 8236), Staphylococcus 
aureus (NCTC 6571), Escherichia coli (ATCC 
25922), Pseudomonas aeruginosa (ATCC 
10145), Candida albicans (ATCC 24433), and 
Candida pseudotropicalis (NCYC 6). The bac- 
terial strains were grown on Nutrient agar 
slopes at 37°C for 24 hours while the fungal 
cultures were grown on Sabouraud’s Dex- 
trose agar slopes for 48 hours at 25°C. The 
organisms were maintained on slopes and 
sub-cultured weekly.  
 
Screening for antibacterial and antifungal 
activities    
 For antibacterial activity testing, 0.5 
mL of 0.5 McFarland standards turbidity sus- 
pension (approx. 1×108 CFU/mL) of each 
bacterial strain was inoculated and spread 
evenly on the surface of over-dried Mueller-
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Hinton (MH) agar plates while for antifungal 
activity testing, 48 h surface culture of each 
fungal strain on Sabouraud’s Dextrose Agar 
(SDA) slopes that were washed off and 
diluted to an inoculum size of 107 CFU/mL 
was used. 0.5 mL of this suspension was 
evenly spread on the surface of over-dried 
SDA plates.     
  The hole-in-plate agar 
diffusion method (23) was used to assess the 
anti- microbial activities of ointment products 
con- taining benzoic acid or salicylic acid (at 
1, 2, 3, 4.5, or 6% w/w concentrations of the 
medi- cament) made by levigation using 
different hydrophilic bases against each test 
organism. A 10g sample of each of the six 
medicated ointments was made for testing, 
Whitfield ointment (Table 1) serving as 
comparator ointment. Three equidistant wells 
(8 mm dia- meter each) were cut into each 
prepared (inoculated) agar plate using a 
sterile cork-borer, and approximately 170mg 
of medi- cated ointment sample for testing 
(0.2mL extruded from a 5mL glass syringe) 
was int- roduced into each well for each 
ointment (test was done in triplicate). The 
plates were refrigerated (4°C) for 1 hour to 
allow for diffusion of incorporated 
medicament and then incubated at 37°C 
aerobically for 24 hr for bacteria and 25°C for 
48 h for fungi. The diameters of inhibition 
zones (in mm) were measured. Bland 
ointment bases were eva- luated alongside 
the medicated ointments as negative control. 
   Following the same 
testing procedure, the antimicrobial activity 
of aqu- eous solution of benzoic acid and 
salicylic acid, each prepared in 50% v/v 
aqueous methanol as solvent (at 0.5, 1, 2, or 
4% w/v concentrations respectively as 
positive cont- rols), was also evaluated 
against each bac- terial and fungal strains. A 
100μL sample of each test solution was 
placed similarly (in triplicate) in equidistant 
wells of appropriately prepared agar plates 
for testing. The 50% aqueous methanol 
solvent alone was eva- luated as negative 
control.  
 
Data analysis    
 The minimum inhibitory concentra- 
tion (MIC) of benzoic acid and salicylic acid 
against each test organism was determined 
by linear regression analysis of the inhibition 
zone sizes produced by each medicament 
over graded concentrations in aqueous meth- 
anol solution, plotted against the logarithm of 
concentration (24). The extents of release of 
the medicaments from different ointment 
bases in 24 h, and correlation of the extents 
against medicament concentration, were 
evaluated for significance using t test. 
Factors influencing the release of medica- 
ment from the bases were investigated by 
Spearman’s rank order correlation of the 
release rate data compared against each of 
four factors namely; the preparation method, 
viscosity under shear of the 3% medicated 
ointments batch, the water number, and 
softening point of the bases. Significance was 




Water number and viscosity of ointments
 Table 2 shows the water number of 
non-medicated bases as well as viscosity of 
the bland and medicated ointments. Among 
the bland bases, emulsifying ointment (EO) 
demonstrated the highest water-sorption 
capacity, with unlimited absorption upon step 
wise addition of water until it converted, in 
the process, to fluid oil-in-water emulsion. 
Lanolin anhydrous (LA) exhibited the next 
highest water number (205.0mL/100g), while 
hydrous sheabutter (HS) showed the least 
water number (10.5mL/100g).   
 All the six ointment bases exhibited 
thixotropic (Bingham plastic) character with 
different yield point stress values: hydrous 
ointment (HO) 50; hydrous sheabutter (HS) 
60; neat sheabutter (NS) 150; lanolin anhy- 
drous (LA) 75; lanolin hydrous (LH) 80; and 
emulsifying ointment (EO) 110 Pa.s, followed 
by decline to a constant viscosity over 15–20s 
of measurement (Fig 2), becoming steady on 
the constant apparent viscosity values of  
hydrous ointment (HO) 12, hydrous shea- 
butter (HS) 10, neat sheabutter (NS) 45, 
lanolin anhydrous (LA) 40, lanolin hydrous 
(LH) 60, and emulsifying ointment (EO) 60 
Pa.s (Table 2).    
 Incorporation of the medicaments 
(benzoic acid or salicylic acid) into the bases 
mostly resulted in ointment products of lower 
viscosity than the bland base. Exception to 
this general observation occurred with HO 
and HS, medicated ointment products of 
which exhibited higher viscosities than those 
of the respective bland vehicles. However, on 
occasions, HS base or its medicated product 
suffered texture-breakdown under levigation 
or fusion processing, accompanied by marked 
reduction in viscosity (Table 2).  
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Heat-stress vulnerability of ointments  
 Heat-tolerance thresholds of the 
ointment bases varied, ranging from the 
37°C softening point of neat sheabutter (NS) 
and of emulsifying ointment (EO) to 56°C, 
the melting point of lanolin hydrous (LH). But 
their softening points were very close to their 
respective congealing point values (within 
±1°C) except for hydrous sheabutter (HS) 
(Table 3).    
 Incorporation of medicament into 
each base caused a drop to lower values of 
heat-tolerance limit of the resultant ointment 
products; except lanolin anhydrous (LA) with 
36°C softening point of the bland base 
against (nearly the same) 35 or 36°C soft- 
ening point value of its medicated ointm- 
ents, and 39°C melting point of the non-med-  
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icated base versus 41-42°C melting point 
values of its medicated ointments, showing 
an increase following medicament incor- 
poration (Table 3). Under mild but protracted 
heating (39-42°C for 10-15 min) required to 
soften or melt HS or NS base for incor- 
poration of medicament, polymorphic trans- 
formation of the base often occurred, 
resulting in weaker, unstable texture of the 
base, which gave ointment products of a 
lower congealing point (≤26°C) than that of 
the precursor base (Table 3).  
 
   
 
Direct correlation of medicament concen- 
tration with release   
 The amounts of each medicament 
released in 24 hours from each medicated 
ointment base were in direct trend with the 
medicament concentrations; 1, 2, and 3% 
respectively (Figs 3 and 4). The increase of 
the amounts of each medicament released in 
24 hours with the stepwise increase in medi- 
cament concentration in benzoic acid oint- 
ments (from 1 to 6% w/w), and in Salicylic 
acid ointments (from 1 to 3% w/w) was, in 













Influence of ointment base on drug release
 Benzoic acid was released to signifi- 
cantly greater extents than salicylic acid in 24 
h from HO, HS, NS, and LA comparing both 
medicaments at same concentrations; 1, 2, 
or 3%, respectively (p<0.01) (Figs 3 and 4). 
The benzoic acid amounts released from HO, 
HS, and NS were comparable (p>0.05) but 
significantly greater than the amounts relea- 
sed from other bases (LA, LH, and EO) in the 
24-h period (p<0.01).    
 Salicylic acid, on the other hand, was 
released to significantly greater (p<0.01) 
extents than benzoic acid from LH over 24 h 
at identical concentrations; 1, 2, and 3%, 
respectively (Figs 3 and 4). But the extents 
of release of the two medicaments from EO 
were not significantly different (p>0.05). The 
delivery of salicylic acid from five ointment 
bases occurred in significantly different 
amounts (p<0.01) in the following descen- 
ding order; HO > HS > NS > EO > LA but its 
release from LA and LH was comparable 
(p>0.05). The trend of the magnitude of 
rates of release of the medicaments from 
different ointment vehicles (Table 4) was 
similar to that found for the extents of 
release of the medicaments. In summary, the  
 
 
three ointment bases, HO, HS and NS, dem- 
onstrated better release property for both 
medicaments than EO, LA and LH.  
 
Other presumed factors had no influence on 
drug delivery   
 Different methods of ointment pre- 
paration, point differences in ointments’ soft- 
ening, various viscosity values under shear, 
and diverse water numbers of the bases did 
not produce significant observable trend 
effects on the rates of release of medicament 
from the medicated ointments studied 
(p>0.05). No correlation was found between 
these parameters and the drug release rate 
data.  
 
Antimicrobial activities of Benzoic acid and 
Salicylic acid in aqueous solution  
 Aqueous methanol solution of each 
medicament at 1% w/v and higher concen- 
trations produced clear zones of inhibition 
against each test organism, while the 50% 
aqueous methanol solvent alone (negative 
control) showed no inhibitory activities. 
Increase of the medicament concentrations 
from 1 through 4% w/v gave correspondingly 
larger inhibition zone sizes (Tables 5 and 6). 
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 Fig 5 illustrates that the logarithm 
values of the MICs of benzoic acid and 
salicylic acid against E. coli, obtained from 
regression lines plotted for the medicaments’ 
inhibitory activities, were ‒0.83 and ‒0.62 
respectively, leading to derivation of the MIC 
values of 0.146% and 0.236% w/v (i.e. 1.46 
and 2.36 mg/mL) respectively. Each MIC 
value for the medicaments (Table 7) was 
similarly determined, being the antilogarithm 
value of the abscissa coordinate (medicament 
concentration) at the intercept of extra- 
polated regression line with the horizontal   
(x-), or log.-concentration axis of the graph 
where y=8.0mm signifying the 8.0mm agar-
well diameter and which (MIC value) could be 
alternatively obtained by algebraic derivation 
from the relevant best-fit line equation (24). 
 Because the MIC values showed the 
relative susceptibilities of the test organisms 
to the antimicrobial activities of the medi- 
caments, they revealed the yeast cells (C. 
albicans and C. pseudotropicalis) to be more 
susceptible than bacterial cells to benzoic 
acid and that C. pseudotropicalis was the 
more sensitive yeast strain (lower MICs: 
0.072 and 7.09 mg/mL) while E. coli was the 
most susceptible bacterial organism to both 
benzoic acid and salicylic acid (least MIC 
values: 1.46 and 2.36 mg/mL) but S. aureus 
was the least sensitive bacterium tested, 
showing the highest MIC values: 2.70 and 
10.00 mg/mL respectively (Table 7).  
 
Antimicrobial activities of Benzoic acid and 
Salicylic acid in ointment products  
 Each medicament incorporated in 
different ointment bases at graded concen- 
trations (1–6% w/w) exhibited clear inhibi- 
tion zones of different sizes against the test 
organisms (Tables 5 and 6), while non-medi- 
cated bases (negative controls) showed no 
inhibitory activities. The medicament concen- 
tration, its MIC relative to each test organism 
and the properties of each base in each 
ointment preparation all interacted multi- 
fariously to determine the antimicrobial 
activity outcomes, summarized as follows; 
 The yeast cells were relatively more 
susceptible than the bacterial cells to the 
inhibitory action of each medicament in 
ointment product. E. coli was the most 
sensitive while P. aeruginosa was the least 
sensitive bacteria to the inhibitory action of 
salicylic acid as medicament in almost all the 
ointment bases. P. aeruginosa was also the 
least sensitive bacterium to benzoic acid as 
medicament in all the six ointment vehicles. 
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However, the relative susceptibility of E. coli, 
B. subtilis, and S. aureus to benzoic acid-
medicated ointments depended on the 
vehicle employed.   
 
Comparison of drug release results to anti- 
microbial activities in ointment  
 Comparison of delivery propensities 
of the medicaments in ointment preparations 
to their antimicrobial activities, in parallel 
study toward elucidating correlations and 
contributing factors, gave the following 
results; two ointment bases, hydrous oint- 
ment (HO) and hydrous sheabutter (HS) 
were prominent as those from which the 
greatest amounts of the active principle, was 
released in the colorimetric drug delivery 
assay, and from which the largest inhibition 
zone sizes were demonstrated by the medi- 
cament. Next to HO and HS were neat shea- 
butter (NS) and emulsifying ointment (EO) of 
approximately equal ranking as regards anti- 
microbial activities, while lanolin hydrous 
(LH) and lanolin anhydrous (LA) were the 
least-performing vehicles.   
 While salicylic acid at 1, 2, and 3% 
w/w concentrations in LH-based ointments 
was released to significantly greater measure 
than benzoic acid, salicylic acid yet exhibited 
poorer antibacterial and antifungal activities 
when compared to benzoic acid ointment 
products in the same vehicle. This vehicle 
(LH) was thus atypical with respect to the 
correlation of antimicrobial ointment activities 
with active-principle delivery propensity of 
vehicle. The antibacterial and antifungal 
activities of all the ointment product samples 
against the most sensitive organism species 
(E. coli and C. pseudotropicalis, respectively) 
were used for this analysis, which provided 




 The efficacy of antimicrobial treat- 
ment of topical infections depends upon ade- 
quate release of the active principle(s) from 
ointment medication following application to 
skin or mucous membrane. Physical pro- 
perties of the ointment vehicle largely deter- 
mine efficiency of release of the active 
principle. This study has examined five hydro- 
philic ointment bases selected from among 
vehicles commonly used in research or pre- 
paration of medicated ointments (25,26,27) 
as possible alternatives to emulsifying oint- 
ment (EO), for improved delivery of benzoic 
acid and salicylic acid in topical antimicrobial 
medication. Improvement of an existing for-
mulation may well involve the selection of a 
superior vehicle on grounds of its better int- 
rinsic qualities for required therapeutic appli- 
cation of the active principle (28).  
 In vitro release studies are useful and 
used for prospective drug delivery efficacy 
testing, to evaluate the relative performance 
of comparable formulations and elucidate 
interactions between the active substance(s) 
and the semisolid base in dermatological 
formulations development (29). The agar dif- 
fusion testing procedure is reputed to corre- 
late significantly with absorption rate through 
the skin for solid medicaments dispersed in 
solid matrices (30,31). The rates and extents 
of release of benzoic acid and salicylic acid 
from the investigated bases, determined in 
the study, integrated the medicaments’ 
delivery profiles from the respective vehicles 
and from the agar medium.  
 Active principle of small particle size 
(≤180μm) was used in the study to aid its 
dissolution in the ointment matrix. However, 
the medicaments did not completely dissolve 
but were suspended (dispersed) in the base 
because their concentrations used (6% w/w 
benzoic acid and 3% w/w salicylic acid; same 
as for the official Whitfield ointment) far 
exceeded their respective aqueous solubility, 
to engender dissolution in the aqua-porous 
phase of hydrophilic bases’ matrix so that 
particulate dispersion ointment products 
resulted. Undissolved drug in a dispersion 
ointment serves as the reservoir from which 
more drug is dissolved as the minute amount 
in solution is liberated.  Drug release from 
suspension-type ointments is reportedly inf- 
luenced by its solubility, diffusion coefficient 
and concentration in the vehicle (21,32). The 
latter factor was corroborated in this study. 
Considering this factor, an alternative app- 
roach to enhancing release and efficacy of 
the active principles could be by increasing 
their concentration or modifying their ratio 
used in the ointments formula (33). However, 
the highest concentration of the active prin- 
ciple tested in this study was fixed at 6% 
because salicylic acid in topical use is known 
to be destructive to dermal tissue above that 
value (34).  
 
Appropriate physical consistency supports 
ointment utility    
 Physical stability is a requirement for 
topical semisolid medicinal products. The 
commonly used dermal antimicrobial oint- 
ments (e.g. of benzoic acid) are required to 
be soft and unctuous but stiff enough to 
remain in place when applied while protective 
ointments (e.g. zinc oxide paste) should be 
hard and stiff remaining in place when 
applied to abraded skin surfaces, and oph- 
thalmic ointments are required to be the 
softest type (35,36). The shear-thinning pro- 
perty of all bases used in the study was 
desirable, predicting ease of skin-surface 
spreading when the ointment would be 
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applied (37), and thus supporting its thera- 
peutic function as well as ensuring storage 
stability of the product (38).   
 Consistency durability of semisolid 
medications (creams and ointments) is 
however affected by heat, hence ointments 
are required to be always stored in a cool 
place. But on application to skin, warm 
human body temperature raises that of the 
applied ointment also to 37°C. Therefore, 
temperature of 37°C is the appropriate and 
desirable softening or melting point for ideal 
ointments (37), so that the body temperature 
would enhance mobility of the incorporated 
medicament in the ointment vehicle and its 
release. All medicated ointments in this study 
showed softening point of 37°C or lower 
(Table 3) thus they met the suitability req- 
uirement. Also, the proximity of the softening 
and congealing points of each ointment base, 
being within ±1°C (except for HS only) 
revealed that the internal three-dimensional 
network structure of the base, formed by its 
components (38), was much stable, with- 
standing disruptive effect of heat stresses 
applied.     
 On the other hand, the relatively 
higher vulnerability of HS base (made from 
NS by fusion) to heat stress was clearly 
attributable to its polymorphic character 
shown also by the significant drop in viscosity 
of its ointment products, accompanied with 
water-leaching. Sheabutter is known to 
exhibit polymorphism, transforming under 
thermal stress into weaker-texture (unstable) 
form having lower softening and melting 
point values than its stable form prior to 
heating (39). The physical consistency weak-
ness of HS base evident in this study was, 
however, advantageous for drug release, in 
that it permitted more extensive delivery and 
greater antimicrobial activities of the incor- 
porated medicaments than most other bases.  
 
Factors contributing to drug delivery in 
ointment    
 Concentration of the active principle 
and appropriate selection of the ointment 
vehicle exert a prominent influence on the 
amounts and activities of the medicament 
released from ointment products, as this 
study has further substantiated. Benzoic acid 
and salicylic acid ointment formulated in four 
bases (HO, HS, NS, and EO) thus demon- 
strated drug release and antimicrobial 
activities superior to ointments made with 
other bases (LA or LH). Ignoring data of the 
latter two bases, trend-agreement was 
evident comparing the in vitro drug release 
data with the antimicrobial activity results. 
Other factors showing potential influence on 
delivery of antimicrobial medicaments in oint- 
ments studied were physical and formulation 
factors (heat stress and medicament intro- 
duced into vehicle, respectively), which 
altered ointment base consistency and sta- 
bility in HS and NS-based products giving 
weaker-texture and lower-viscosity out- 
comes. The processing methods (fusion and 
levigation) were other factors, which caused 
polymorphism-related “bleeding” of the HS-
based ointments. The HS bleeding was a rev- 
ersal of water-incorporation into the base 
achieved at its compounding stage, and a 
form of syneresis. Syneresis is the separation 
of liquid (often the solvent phase) from 
polymeric materials (e.g. gels) constituted by 
aqueous and non-aqueous macromolecular 
units; a form of instability caused by shrin- 
king of the three-dimensional gel network 
holding the liquid phase within the stable 
polymer structure (36).  
 Consistency alteration of ointment 
should expectedly influence its drug delivery 
rate particularly on ageing, because the rheo- 
logical property determines the value of 
diffusion coefficient of the active substance in 
the formulation (1,29). Incorporation of the 
medicament into ointment base in this study 
generally caused decrease, but sometimes 
increase, of viscosity of the resulting medi- 
cated ointments. Sinko (40) had stated that 
the rheological property of semisolid products 
is altered by incorporation of medicament 
into the vehicle, spreading the product on 
skin, or by milling operation. Yet, statistical 
comparison of the physical consistency para- 
meter (viscosity values) of different ointment 
preparations of this study to release rates of 
their incorporated medicament was found to 
be not significant. Lack of significant impact 
of the rheological property of pharmaceutical 
semisolids on drug release has been similarly 




 Benzoic acid exhibited stronger anti- 
microbial activities against most test 
organisms than salicylic acid in ointment 
preparations. There was correlation between 
release and antimicrobial activities of the 
medicaments in ointments produced using 
bases that permitted ample delivery of 
incorporated medicament. The drug delivery 
and activity appraisals increased with 
increase of drug concentration. Hydrous 
ointment and hydrous sheabutter bases 
demonstrated the highest levels of both 
antibacterial and antifungal properties, and 
the greatest amounts of the active principles 
released; followed by neat sheabutter and 
emulsifying ointment. Water number of the 
bases, or viscosity or heat-stress tolerance of 
bland or medicated ointments and method of 
ointment preparation did not demonstrate 
any direct influence on the rate of drug 
delivery from ointment vehicles.  
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